Syndrome resembling Addison's disease following prolonged treatment with busulphan.
作者信息
Harrold B P
出版信息
Br Med J. 1966 Feb 19;1(5485):463-4. doi: 10.1136/bmj.1.5485.463.
Abstract
摘要
相似文献
1
Syndrome resembling Addison's disease following prolonged treatment with busulphan.长期使用白消安治疗后出现类似艾迪生病的综合征。
Br Med J. 1966 Feb 19;1(5485):463-4. doi: 10.1136/bmj.1.5485.463.
2
Two cases of busulfan toxicity.两例白消安毒性病例。
Ann Intern Med. 1966 Jan;64(1):154-64. doi: 10.7326/0003-4819-64-1-154.
3
Pigmentation and busulphan therapy.色素沉着与白消安治疗
Br Med J. 1966 Mar 19;1(5489):736-7. doi: 10.1136/bmj.1.5489.736-d.
4
[Undesired side-effects of busulfan].
Dtsch Med Wochenschr. 1974 Dec 20;99(51):2614-5. doi: 10.1055/s-0028-1108180.
5
The syndrome of congenital adrenocortical unresponsiveness to ACTH. Report of six cases.
Pediatr Res. 1968 Nov;2(6):501-13. doi: 10.1203/00006450-196811000-00008.
6
Longitudinal melanonychia as the first sign of Addison's disease.纵向黑甲作为艾迪生病的首发症状。
J Am Acad Dermatol. 2008 Mar;58(3):522-4. doi: 10.1016/j.jaad.2006.06.039.
7
Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
Scand J Respir Dis. 1972;53(5):265-73.
8
Patients presenting with Addison's disease need not be pigmented.患有艾迪生病的患者不一定会有色素沉着。
Postgrad Med J. 1982 Nov;58(685):690-2. doi: 10.1136/pgmj.58.685.690.
9
Crisis? What crisis? Abdominal pain and darkening skin in Addison's disease.危机？什么危机？艾迪生病中的腹痛与皮肤变黑。
Lancet. 2020 Aug 15;396(10249):498. doi: 10.1016/S0140-6736(20)31680-9.
10
[Cutaneous pigmentations during myeloid leukemia treated with myleran].[用马利兰治疗髓细胞白血病期间的皮肤色素沉着]
Sem Ther. 1963 Nov;39(9):565-8.
引用本文的文献
1
Drug-Induced Pigmentation: A Review.药物诱导性色素沉着：综述。
Drugs. 2024 Sep;84(9):1071-1091. doi: 10.1007/s40265-024-02062-z. Epub 2024 Aug 1.
2
Endocrine sequelae of cancer and cancer treatments.癌症及癌症治疗的内分泌后遗症。
J Cancer Surviv. 2007 Dec;1(4):261-74. doi: 10.1007/s11764-007-0038-6. Epub 2007 Nov 20.
3
Lung damage from cytotoxic drugs.细胞毒性药物所致的肺损伤。
Cancer Chemother Pharmacol. 1980;4(1):17-27. doi: 10.1007/BF00255453.
4
Busulphan lung.白消安肺
Thorax. 1968 Mar;23(2):187-93. doi: 10.1136/thx.23.2.187.
5
Drug eruptions.
Postgrad Med J. 1985 Oct;61(720):925-33. doi: 10.1136/pgmj.61.720.925.
6
An investigation of the chest radiographs in a controlled trial of busulphan, cyclophosphamide, and a placebo after resection for carcinoma of the lung.在一项针对肺癌切除术后使用白消安、环磷酰胺及安慰剂的对照试验中对胸部X光片的调查。
Thorax. 1976 Jun;31(3):265-70. doi: 10.1136/thx.31.3.265.
本文引用的文献
1
A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy.
Blood. 1961 Nov;18:497-510.
2
DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AFTER BUSULPHAN THERAPY.白消安治疗后弥漫性间质性肺纤维化
Lancet. 1963 Aug 31;2(7305):432-4. doi: 10.1016/s0140-6736(63)92173-1.
3
Interstitial pulmonary fibrosis following busulfan therapy.白消安治疗后发生的间质性肺纤维化。
Am J Med. 1961 Jul;31:134-9. doi: 10.1016/0002-9343(61)90229-7.
4
5
[1-4 Dimetanosulfoniloxibutano (GT 41 - myleran) in the treatment of chronic myelogenous leukemia].[1-4 二甲基磺酰氧丁烷（GT 41 - 马利兰）治疗慢性粒细胞白血病]
Arq Bras Med. 1956 May-Jun;46(5-6):161-72.
6
Myleran in chronic myeloid leukaemia; results of treatment.马利兰治疗慢性粒细胞白血病的疗效
Lancet. 1953 Jan 31;264(6753):208-13. doi: 10.1016/s0140-6736(53)90885-x.
Zotero 插件